Testing effectiveness (Phase 2)UnknownNCT01558245
What this trial is testing
Tissue Kallikrein Preventing the Restenosis After Stenting of Symptomatic MCA Atherosclerotic Stenosis
Who this might be right for
Cerebrovascular Disease
Jinling Hospital, China 99